News from biodelivery sciences international, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 14, 2015, 07:00 ET
BDSI Logo.

BioDelivery Sciences Announces Hiring of Enoch Bortey, Ph.D., as Vice President of Clinical Biostatistics and Data Systems

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that Enoch Bortey, Ph.D., has joined the company as Vice President of...

Jun 08, 2015, 07:00 ET
BDSI Logo.

BioDelivery Sciences Announces Hiring of Stephana E. Patton as General Counsel

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that Stephana E. Patton, Ph.D., J.D. has joined that company as Vice...

Jun 02, 2015, 09:50 ET

BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that due to weather conditions, the presentation by Dr. Mark A. Sirgo, President...

Jun 01, 2015, 07:00 ET
BDSI Logo

BioDelivery Sciences Adds $20 Million in Debt Financing from MidCap Financial

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that it has secured an additional $20.7 million in gross debt funding...

May 28, 2015, 07:00 ET
BDSI Logo.

BioDelivery Sciences Strengthens BUNAVAIL Sales and Managed Markets Teams

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) has strengthened its sales and managed markets teams to support the launch of...

May 27, 2015, 07:00 ET
BDSI Logo.

BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...

May 11, 2015, 07:00 ET
BUNAVAIL Monthly Total Prescriptions

BioDelivery Sciences Provides Corporate Update and Reports First Quarter 2015 Financial Results

  BUNAVAIL® (buprenorphine and naloxone) buccal film showed a 25% average month-over-month growth in prescription sales over the quarter...

May 04, 2015, 07:00 ET

BioDelivery Sciences to Host Conference Call and Webcast of First Quarter 2015 Results on Monday, May 11

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it will report its first quarter ended March 31, 2015 financial results...

Apr 30, 2015, 14:00 ET

BioDelivery Sciences to Present at the Deutsche Bank 40th Annual Health Care Conference and the Bank of America Merrill Lynch 2015 Health Care Conference

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...

Apr 28, 2015, 07:00 ET

BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of Clinical Research and Medical Affairs

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) has appointed Sarah DeRossett, MD, PhD to the position of Vice President of Clinical...

Mar 30, 2015, 06:30 ET

BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that the primary efficacy endpoint in the Phase 3 clinical study of...

Mar 16, 2015, 16:03 ET

BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Year-End 2014 Financial Results

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) today reported financial results for the fourth quarter and fiscal year ended December...

Mar 09, 2015, 07:00 ET
BDSI Logo

BioDelivery Sciences to Host Conference Call and Webcast of Fourth Quarter and Year End 2014 Results on Monday, March 16

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it will report its fourth quarter and year end 2014 financial results...

Mar 03, 2015, 07:00 ET
BDSI Logo.

BioDelivery Sciences to Present at the 27th Annual ROTH Conference

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...

Feb 23, 2015, 09:00 ET
BDSI Logo.

BioDelivery Sciences to Receive $10 Million Milestone Payment from Endo Pharmaceuticals Inc. in Conjunction with Acceptance of NDA for BELBUCA™ (buprenorphine HCl) Buccal Film for Chronic Pain

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) and Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP)...

Feb 18, 2015, 07:00 ET
BDSI Logo

BioDelivery Sciences to Present at the 2015 RBC Capital Markets Healthcare Conference

 BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will...

Jan 27, 2015, 07:00 ET
BDSI Logo

BioDelivery Sciences Acquires North American Marketing Authorizations for ONSOLIS from Meda

 BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that it has entered into an assignment and revenue sharing agreement...

Dec 23, 2014, 15:42 ET

Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain

 Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), and BioDelivery Sciences International, Inc....

Dec 10, 2014, 08:00 ET
BDSI Logo.

BioDelivery Sciences Launches InReach Support Program for Those Affected by Opioid Dependence

BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI), who recently launched BUNAVAIL® (buprenorphine and naloxone) buccal film...

Dec 08, 2014, 07:00 ET
BDSI Logo

BioDelivery Sciences Announces Completion of Randomization in Phase 3 Trial of Clonidine Topical Gel for the Treatment of Painful Diabetic Neuropathy

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has completed the randomization of all patients in BDSI's ongoing initial...